Neurological Sciences

, Volume 39, Issue 9, pp 1617–1619 | Cite as

Acute myelitis as presentation of a reemerging disease: measles

  • I. ColomboEmail author
  • E. Forapani
  • C. Spreafico
  • C. Capraro
  • I. Santilli
Letter to the Editor

Dear editor,

Over the last few months, Europe has witnessed an outbreak of measles mostly in adolescents and young adults. According to the last report on measles from European Centre for Disease Prevention and Control, over the first 6 months of 2017, 10,866 cases have been reported, mostly in Italy and Romania (respectively 37 and 36%), with the 86% of affected unvaccinated [1]. Though vaccination was introduced in Italian national schedule about 20 years ago, after 2007, a decreasing trend in coverage has been observed [2]. Measles vaccination is one of the most effective health interventions ever developed. Without the vaccine, five million children would die each year from measles—assuming an estimated case-fatality rate of 2–3% [3]. In adults, respiratory and neurological complications account as main causes of hospitalization in acute phase [4]. Here, we present a case of measles with severe neurological impairment in a young unvaccinated woman.

On January 2017, a 32-year-old...


Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.


  1. 1.
    European Centre for Disease Prevention and Control. Bi-annual measles and rubella monitoring report, October 2017. Stockholm: ECDC; 2017. Available from: Scholar
  2. 2.
    Amendola A, Bubba L, Piralla A et al (2015) Surveillance and vaccination coverage of measles and rubella in Northern Italy. Hum VaccinImmunother 11(1):206–213Google Scholar
  3. 3.
    Perry RT, Halsey N (2004) The clinical significance of measles: a review. J Infect Dis 189(Suppl 1):S4–S16Google Scholar
  4. 4.
    Buchanan R, Bonthius DJ (2012 Sep) Measles virus and associated central nervous system sequelae. Semin Pediatr Neurol 19(3):107–114CrossRefPubMedGoogle Scholar
  5. 5.
    Rafat C, Klouche K, Ricard JD, Messika J, Roch A, Machado S, Sonneville R, Guisset O, Pujol W, Guérin C, Teboul JL, Mrozek N, Darmon M, Chemouni F, Schmidt M, Mercier E, Dreyfuss D, Gaudry S (2013) Severe measles infection: the spectrum of disease in 36 critically ill adult patients. Medicine (Baltimore) 92:257–272CrossRefGoogle Scholar
  6. 6.
    Baba Y, Tsuboi Y, Inoue H, Yamada T, Wszolek ZK, Broderick DF (2006) Acute measles encephalitis in adults. J Neurol 253(1):121–124CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia S.r.l., part of Springer Nature 2018

Authors and Affiliations

  1. 1.Neurology Department and Stroke UnitHospital of Desio, ASST MonzaDesioItaly
  2. 2.Neuroradiology ServiceSan Gerardo Hospital, ASST MonzaMonzaItaly

Personalised recommendations